# Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement

> **NCT06143306** · PHASE4 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 110 (estimated)

## Conditions studied

- Total Shoulder Arthroplasty

## Interventions

- **DRUG:** bupivacaine.
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06143306
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-05-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143306, "Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06143306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*